Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2014
08/13/2014CN102885794B 一种口含干扰素片剂及其制备方法 An oral tablet containing interferon and its preparation method
08/13/2014CN102784397B 用锂皂石粘土纳米颗粒负载阿霉素盐酸盐抗癌药物的方法 With hectorite clay nanoparticles load anticancer drug doxorubicin hydrochloride method
08/13/2014CN102781425B 含有维生素d类似物以及溶剂和表面活性剂混合物的皮肤用组合物 Skin equivalent and a solvent, and a surfactant mixture containing vitamin composition d
08/13/2014CN102766215B 一种具有协同靶向诊疗鼻咽癌功能的多肽和携带此多肽的纳米颗粒及其应用 Having a synergistic treatment of NPC function targeting peptides and nanoparticles carrying the polypeptide and its application
08/13/2014CN102743796B 用聚乙烯醇制成的丝素蛋白多孔支架及其制备方法和用途 Made with polyvinyl silk fibroin porous scaffold and its preparation method and use
08/13/2014CN102702451B 一种pH敏感且生物相容高效抗菌的聚合物胶束及其制备方法 One pH sensitive and efficient antibacterial biocompatible polymer micelle and its preparation method
08/13/2014CN102697754B 厄贝沙坦胶囊及其制备方法 Irbesartan capsule and its preparation method
08/13/2014CN102631689B 一种用于诊疗的磁共振成像造影剂及其制备方法 A magnetic resonance imaging contrast agent treatment and preparation methods for
08/13/2014CN102600065B 一种氟维司群或其衍生物油性制剂及其制备方法 One kind of fulvestrant or a derivative thereof oil and its preparation method
08/13/2014CN102552215B 微囊冻干粉及其制备方法 Microcapsules lyophilized powder and its preparation method
08/13/2014CN102505176B 一种锂皂石掺杂的聚乳酸-羟基乙酸纳米纤维的制备方法 A hectorite doped polylactic - Preparation of a hydroxy acid nanofibers
08/13/2014CN102219986B 生物可降解的聚己二酸-对苯二甲酸-丁二醇酯中空发泡粒子及其制备方法 Biodegradable polybutylene adipate - terephthalate - polybutylene terephthalate foamed hollow particles and a method for preparing
08/13/2014CN102216334B 包含被疏水性醇的衍生物取代的羧基官能团的多糖 Hydrophobic polysaccharide substituted alcohol derivatives containing carboxyl functional group
08/13/2014CN102176913B 外用的他克莫司制剂 Topical tacrolimus formulations
08/13/2014CN102133239B 一种中药浓缩丸及其制备方法 A traditional Chinese medicine pill and its preparation method
08/13/2014CN102038636B 一种含有螯合剂的紫杉烷类药物溶液及其制备方法 A chelating agent is a taxane-containing solution and a preparation method
08/13/2014CN101906145B 两根Arg-Gly-Asp-Val链通过Lys与一根脂肪醇链的偶联物、它们的合成及在医学中的应用 Two Arg-Gly-Asp-Val-chain conjugates by Lys with a fatty chain, their synthesis and applications in medicine
08/13/2014CN101785861B 用于药理活性化合物的可控释放的可注射组合物 Injectable compositions for the controlled release of pharmacologically active compounds
08/13/2014CN101160403B 转运化合物穿过血脑屏障的分子 Transporter molecule compound across the blood-brain barrier
08/13/2014CA2852867A1 Combination formulation of two antiviral compounds
08/12/2014USRE45073 Earth alkali (hydr)oxide for preventing caking of powdered emulsifiers
08/12/2014US8802837 Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer
08/12/2014US8802824 Modified recombinant human endostatin and uses thereof
08/12/2014US8802773 In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
08/12/2014US8802738 Polyesters with grafted zwitterions
08/12/2014US8802736 High concentration capsaicinoid pain relief composition
08/12/2014US8802667 Benzodiazepine derivatives
08/12/2014US8802644 Lipid formulation
08/12/2014US8802626 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
08/12/2014US8802622 Composition for nasal administration and method for preparing same
08/12/2014US8802397 Method of producing the polypeptide for treating virus-induced cancer
08/12/2014US8802179 Non-digestible sugar-coated products and process
08/12/2014US8802158 Methods of use of probiotic Lactobacilli for companion animals
08/12/2014US8802151 Preparation of shaped metal particles and their uses
08/12/2014US8802147 Controlled release of biologically active compounds
08/12/2014US8802144 3-dimensional cardiac fibroblast derived extracellular matrix
08/12/2014US8802133 Silicone scar treatment preparation
08/12/2014US8802129 Methods for treating retinopathy with extended therapeutic effect
08/12/2014US8802125 Controlled-delivery system of pharmacologically active substances, preparation process and medical use thereof
08/12/2014US8802116 Poloxamer emulsion preparations
08/12/2014US8802114 Pharmaceutical compositions of iron for oral administration
08/12/2014US8802102 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802101 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802100 Formulation of human antibodies for treating TNF-alpha associated disorders
08/12/2014US8802088 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
08/12/2014US8802072 Biocompatible adhesive materials and methods
08/12/2014US8802061 Aqueous disinfectants and sterilants for skin and mucosal application
08/12/2014US8801955 Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preparation thereof
08/12/2014CA2776927C Phosphorylcholine conjugates and corresponding antibodies
08/12/2014CA2680433C Novel composition based on cholest-4-ene-3-one oxime
08/12/2014CA2658736C Method for the production of insulin-like growth factor-i
08/12/2014CA2647450C Process for producing a staphylococcal conjugate
08/12/2014CA2607663C Compositions and methods for increasing the stability of antibodies
08/12/2014CA2599017C Compositions and methods for topical application and transdermal delivery of botulinum toxins
08/12/2014CA2571565C Dimensional analysis of saccharide conjugates with gpc & sec-mals
08/12/2014CA2551813C Compositions and methods for the treatment of tumor of hematopoietic origin
08/12/2014CA2520392C Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding
08/12/2014CA2492047C Short duration depot formulations
08/07/2014WO2014121232A1 Artificial tears comprising sodium hyaluronate and carboxymethylcellulose
08/07/2014WO2014121224A2 Biodegradable iron oxide nanoparticle gel for tumor bed therapy
08/07/2014WO2014121050A1 Functionalized dna dendrimers for gene delivery to cells
08/07/2014WO2014121048A2 Topical compositions and methods for making and using same
08/07/2014WO2014120974A1 Selective delivery molecules and methods of use
08/07/2014WO2014120837A2 Pretargeted activatable cell penetrating peptide with intracellulary releaseable prodrug
08/07/2014WO2014119836A1 Pharmaceutical composition for protecting wounds, providing hemostasis, or preventing adhesion in the gastrointestinal tract
08/07/2014WO2014119823A1 Pharmaceutical composition for reducing or inhibiting scar formation, containing bmp-7 and diluting agent
08/07/2014WO2014118553A1 Nested supramolecular capsules
08/07/2014WO2014118355A1 Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
08/07/2014WO2014117999A1 Compositions and methods for treating chronic inflammation and inflammatory diseases
08/07/2014WO2014117265A1 Liquid menthol compositions
08/07/2014WO2014117253A1 J-aggregate forming nanoparticle
08/07/2014US20140222134 Functionalized rgd peptidomimetics and their manufacture, and implant having a coating containing such functional-ized rgd peptidomimetics
08/07/2014US20140221942 A Device for the Transdermal Delivery of Alkaline Compounds that are Susceptible to Degradation in Their Free Base Form
08/07/2014US20140221922 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
08/07/2014US20140221623 Interleukin-6 receptor binding polypeptides
08/07/2014US20140221621 Single-chain multivalent binding protein compositions and methods
08/07/2014US20140221612 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and Methods
08/07/2014US20140221577 Self-assembled particles from zwitterionic polymers and related methods
08/07/2014US20140221569 Decorated macromolecular scaffolds
08/07/2014US20140221501 Therapeutic foam
08/07/2014US20140221490 Methods of treating pain
08/07/2014US20140221489 Infusion and Injection Solution of Levodopa
08/07/2014US20140221488 Injectable Melphalan Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same
08/07/2014US20140221459 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/07/2014US20140221321 Compositions and Methods for the Treatment of Neurodegenerative and Other Diseases
08/07/2014US20140221306 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
08/07/2014US20140221295 Modified binding proteins inhibiting the vegf-a receptor interaction
08/07/2014US20140221292 Polyionic dendrimer and hydrogel comprising same
08/07/2014US20140221290 Stabilizing agent for pharmaceutical proteins
08/07/2014US20140221289 Thixotropic A-Lactalbumin Hydrogels, Method for Preparing Same and Uses Thereof
08/07/2014US20140221283 Glucagon/glp-1 receptor co-agonists
08/07/2014US20140221282 Long duration dual hormone conjugates
08/07/2014US20140221274 Low impurity content caspofungin preparation, method for preparing same, and use thereof
08/07/2014US20140221272 Reconstituted hdl formulation
08/07/2014US20140221271 Shk-based pharmaceutical compositions and methods of manufacturing and using the same
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220346 Modular polymer hydrogel nanoparticles and methods of their manufacture
08/07/2014US20140220143 Immune-stimulating photoactive hybrid nanoparticles
08/07/2014US20140220139 Skin composition for external use containing ceramides
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 1712